DES Makers, Hospitals Will Not Get Higher-Paying DRG In FY 2004 – Scully

Competition provided by additional drug-eluting stent players in the U.S. ultimately will drive down pricing, making it unnecessary to further increase reimbursement for the technology in FY 2004, CMS Administrator Tom Scully asserted